Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

WOMED

Financiado

WOMED: an innovative intrauterine biodegradable polymer-based drug-delivery plat...

WOMED: an innovative intrauterine biodegradable polymer-based drug-delivery platform Every woman experiences some form of uterine disorder during her lifetime, including excessive bleeding, pelvic pain, and fertility issues, posing an enormous burden for women worldwide. Current treatments have limitations & painf... ver más

30/04/2026

WOMED

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

WOMED No se ha especificado una descripción o un objeto social para esta compañía.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-05-06

HORIZON-EIC-2023-ACCELERATOROPEN-01: EIC Accelerator Open 2023 Scope:The EIC Accelerator Open has no predefined thematic priorities and is open to proposals in any...

I+D

Cerrada hace 1 año

0% 70% 100%

1 Participantes

WOMED

2.49M€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

Avodes-Biotech Avodes - biotechnological menstrual product for Candidiasis... 75K€ Cerrado

SONOPHORESIS SMARTPATCH Sonophoresis smartpatch for pain-free, controllable, and wea... 4M€ Cerrado

Micropod MICROPOrous Devices for next generation therapeutic delivery 188K€ Cerrado

PRE2018-085440 BUSQUEDA DE BIOMARCADORES Y DESAROLLO DE UN TEST MOLECULAR D... 93K€ Cerrado

DESARROLLO DE UNA TECNOLOGÍA DE LIBERACIÓN CO... DESARROLLO DE UNA TECNOLOGÍA DE LIBERACIÓN CONTROLADA DE USO... 30K€ Cerrado

EmboPore An injectable and programmable drug-eluting embolic device 150K€ Cerrado

Duración del proyecto: 23 meses Fecha Inicio: 2024-05-06
Fecha Fin: 2026-04-30

Líder del proyecto

WOMED No se ha especificado una descripción o un objeto social para esta compañía.

Presupuesto del proyecto 4M€

Descripción del proyecto Every woman experiences some form of uterine disorder during her lifetime, including excessive bleeding, pelvic pain, and fertility issues, posing an enormous burden for women worldwide. Current treatments have limitations & painful side effects. Fibroids and endometriosis are two of the most relevant unmet needs in women health. For fibroids, an extremely common condition affecting 51% of women between 35-49, the withdrawal of Esmya, a highly appreciated treatment, has left a gap in effective options. Meanwhile, women with endometriosis (10% women in reproductive years) suffer incapacitating pain that is poorly managed with systemic analgesics. There is an urgent need for better treatments. Womed was founded in Montpellier by Gonzague Issenmann, a serial MedTech entrepreneur, to revolutionize the women health industry by changing the paradigm of uterine disorders treatment. Womed develops safe and effective local intrauterine therapies. Our unique and patented copolymer structure allows for easy insertion, biodegradability and sustained and controlled local drug delivery. Our first product, Womed Leaf, is a drug-free intrauterine device that prevents adhesions and restores fertility. Based on Leaf’s design, we are developing a uterine drug delivery platform with Fibroid, a preoperative treatment for fibroids, and ReLeaf, a nonhormonal treatment to alleviate endometriosis-related pain.

Conecta tu I+D

Entra hoy

¿Olvide mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores